Latest news

March 24, 2025
/
News

FDA-Cleared Digital Treatments are Shaping the Future of Mental Healthcare

New JAMA Study Showcases Clinical Benefits of SleepioRx in Patients with Comorbid Insomnia and Depression Symptoms, Marking 100+ Peer-Reviewed Papers for Big Health
March 10, 2025
/
News
US FDA Grants Clearance for DaylightRx
September 4, 2024
/
News
US FDA Grants Clearance for SleepioRx
August 8, 2024
/
News
Study Finds Spark Direct Effective in Improving Mood Among Adults With Depression
May 23, 2024
/
News

All News

Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix
Leader in Digital Therapeutics Adds to Existing Insomnia and Anxiety Treatments to Address the Youth Mental Health Crisis
July 14, 2023
/
News
Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix
Big Health partners with the American Psychological Association to increase awareness of the value and impact of digital treatments in clinical care delivery.
July 14, 2023
/
News
Digital therapeutics: at an inflection point
Five questions with Big Health CEO Arun Gupta
April 24, 2023
/
News
For many with mental health conditions, medication is the only option. That has to change.
Let’s bring clinically proven, non-drug digital treatments front and center to help millions in need.
January 26, 2023
/
News
Big Health Builds Out Its Leadership Team with the Appointment of Five Key Executives
Company ramps up next phase of growth in 2023 after record breaking year
January 10, 2023
/
News
Big Health Digital Therapeutics Daylight and Sleepio Selected for Evernorth Digital Health Formulary
The addition of Daylight for anxiety and Sleepio for insomnia expands access to evidence-based digital cognitive behavioral therapy to thousands of Americans
September 15, 2022
/
News
Let's talk
For all media-related queries, please get in touch with us.
Who we are
Learn about our mission, leadership, advisors, and investors.